ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-Ageing Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-9B7183
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti Ageing Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Anti-Ageing Drugs Market Research Report 2025

Code: QYRE-Auto-9B7183
Report
September 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Nu Skin
BioTime
Elysium Health
La Roche-Posay
DermaFix

Anti-Ageing Drugs Market Size

The global market for Anti-Ageing Drugs was valued at US$ 97310 million in the year 2024 and is projected to reach a revised size of US$ 160320 million by 2031, growing at a CAGR of 7.5% during the forecast period.

Anti-Ageing Drugs Market

Anti-Ageing Drugs Market

Anti-aging drugs are used to slow down or reverse the processes of aging to extend the lifespan. Aging, is that damage to the body’s macromolecules, cells, tissues, which is facilitated by genomic instability, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, oxidation damage by free radicals etc
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-Ageing Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Ageing Drugs.
The Anti-Ageing Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-Ageing Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Ageing Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anti-Ageing Drugs Market Report

Report Metric Details
Report Name Anti-Ageing Drugs Market
Accounted market size in year US$ 97310 million
Forecasted market size in 2031 US$ 160320 million
CAGR 7.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Skin
  • Hair
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Nu Skin, BIOTIME, Elysium Health, La Roche-Posay, DermaFix
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anti-Ageing Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anti-Ageing Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Anti-Ageing Drugs Market growing?

Ans: The Anti-Ageing Drugs Market witnessing a CAGR of 7.5% during the forecast period 2025-2031.

What is the Anti-Ageing Drugs Market size in 2031?

Ans: The Anti-Ageing Drugs Market size in 2031 will be US$ 160320 million.

Who are the main players in the Anti-Ageing Drugs Market report?

Ans: The main players in the Anti-Ageing Drugs Market are Nu Skin, BIOTIME, Elysium Health, La Roche-Posay, DermaFix

What are the Application segmentation covered in the Anti-Ageing Drugs Market report?

Ans: The Applications covered in the Anti-Ageing Drugs Market report are Skin, Hair, Others

What are the Type segmentation covered in the Anti-Ageing Drugs Market report?

Ans: The Types covered in the Anti-Ageing Drugs Market report are Hormonal Therapy, Antioxidants, Enzymes, Stem Cells, Others

Recommended Reports

Anti-Aging Solutions

Pharmaceutical Drugs

Disease Treatments

1 Anti-Ageing Drugs Market Overview
1.1 Product Definition
1.2 Anti-Ageing Drugs by Type
1.2.1 Global Anti-Ageing Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Hormonal Therapy
1.2.3 Antioxidants
1.2.4 Enzymes
1.2.5 Stem Cells
1.2.6 Others
1.3 Anti-Ageing Drugs by Application
1.3.1 Global Anti-Ageing Drugs Market Value by Application (2024 VS 2031)
1.3.2 Skin
1.3.3 Hair
1.3.4 Others
1.4 Global Anti-Ageing Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Ageing Drugs Revenue 2020-2031
1.4.2 Global Anti-Ageing Drugs Sales 2020-2031
1.4.3 Global Anti-Ageing Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti-Ageing Drugs Market Competition by Manufacturers
2.1 Global Anti-Ageing Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti-Ageing Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti-Ageing Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti-Ageing Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Ageing Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Ageing Drugs, Product Type & Application
2.7 Global Key Manufacturers of Anti-Ageing Drugs, Date of Enter into This Industry
2.8 Global Anti-Ageing Drugs Market Competitive Situation and Trends
2.8.1 Global Anti-Ageing Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-Ageing Drugs Players Market Share by Revenue
2.8.3 Global Anti-Ageing Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-Ageing Drugs Market Scenario by Region
3.1 Global Anti-Ageing Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti-Ageing Drugs Sales by Region: 2020-2031
3.2.1 Global Anti-Ageing Drugs Sales by Region: 2020-2025
3.2.2 Global Anti-Ageing Drugs Sales by Region: 2026-2031
3.3 Global Anti-Ageing Drugs Revenue by Region: 2020-2031
3.3.1 Global Anti-Ageing Drugs Revenue by Region: 2020-2025
3.3.2 Global Anti-Ageing Drugs Revenue by Region: 2026-2031
3.4 North America Anti-Ageing Drugs Market Facts & Figures by Country
3.4.1 North America Anti-Ageing Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti-Ageing Drugs Sales by Country (2020-2031)
3.4.3 North America Anti-Ageing Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Ageing Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-Ageing Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti-Ageing Drugs Sales by Country (2020-2031)
3.5.3 Europe Anti-Ageing Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Ageing Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-Ageing Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti-Ageing Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti-Ageing Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Ageing Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-Ageing Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti-Ageing Drugs Sales by Country (2020-2031)
3.7.3 Latin America Anti-Ageing Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Ageing Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Ageing Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti-Ageing Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti-Ageing Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-Ageing Drugs Sales by Type (2020-2031)
4.1.1 Global Anti-Ageing Drugs Sales by Type (2020-2025)
4.1.2 Global Anti-Ageing Drugs Sales by Type (2026-2031)
4.1.3 Global Anti-Ageing Drugs Sales Market Share by Type (2020-2031)
4.2 Global Anti-Ageing Drugs Revenue by Type (2020-2031)
4.2.1 Global Anti-Ageing Drugs Revenue by Type (2020-2025)
4.2.2 Global Anti-Ageing Drugs Revenue by Type (2026-2031)
4.2.3 Global Anti-Ageing Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Anti-Ageing Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti-Ageing Drugs Sales by Application (2020-2031)
5.1.1 Global Anti-Ageing Drugs Sales by Application (2020-2025)
5.1.2 Global Anti-Ageing Drugs Sales by Application (2026-2031)
5.1.3 Global Anti-Ageing Drugs Sales Market Share by Application (2020-2031)
5.2 Global Anti-Ageing Drugs Revenue by Application (2020-2031)
5.2.1 Global Anti-Ageing Drugs Revenue by Application (2020-2025)
5.2.2 Global Anti-Ageing Drugs Revenue by Application (2026-2031)
5.2.3 Global Anti-Ageing Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Anti-Ageing Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Nu Skin
6.1.1 Nu Skin Company Information
6.1.2 Nu Skin Description and Business Overview
6.1.3 Nu Skin Anti-Ageing Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Nu Skin Anti-Ageing Drugs Product Portfolio
6.1.5 Nu Skin Recent Developments/Updates
6.2 BIOTIME
6.2.1 BIOTIME Company Information
6.2.2 BIOTIME Description and Business Overview
6.2.3 BIOTIME Anti-Ageing Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BIOTIME Anti-Ageing Drugs Product Portfolio
6.2.5 BIOTIME Recent Developments/Updates
6.3 Elysium Health
6.3.1 Elysium Health Company Information
6.3.2 Elysium Health Description and Business Overview
6.3.3 Elysium Health Anti-Ageing Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Elysium Health Anti-Ageing Drugs Product Portfolio
6.3.5 Elysium Health Recent Developments/Updates
6.4 La Roche-Posay
6.4.1 La Roche-Posay Company Information
6.4.2 La Roche-Posay Description and Business Overview
6.4.3 La Roche-Posay Anti-Ageing Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 La Roche-Posay Anti-Ageing Drugs Product Portfolio
6.4.5 La Roche-Posay Recent Developments/Updates
6.5 DermaFix
6.5.1 DermaFix Company Information
6.5.2 DermaFix Description and Business Overview
6.5.3 DermaFix Anti-Ageing Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 DermaFix Anti-Ageing Drugs Product Portfolio
6.5.5 DermaFix Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Ageing Drugs Industry Chain Analysis
7.2 Anti-Ageing Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Ageing Drugs Production Mode & Process Analysis
7.4 Anti-Ageing Drugs Sales and Marketing
7.4.1 Anti-Ageing Drugs Sales Channels
7.4.2 Anti-Ageing Drugs Distributors
7.5 Anti-Ageing Drugs Customer Analysis
8 Anti-Ageing Drugs Market Dynamics
8.1 Anti-Ageing Drugs Industry Trends
8.2 Anti-Ageing Drugs Market Drivers
8.3 Anti-Ageing Drugs Market Challenges
8.4 Anti-Ageing Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Nu Skin
BioTime
Elysium Health
La Roche-Posay
DermaFix
List of Tables
 Table 1. Global Anti-Ageing Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Anti-Ageing Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Anti-Ageing Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Anti-Ageing Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Anti-Ageing Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Anti-Ageing Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Anti-Ageing Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Anti-Ageing Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Anti-Ageing Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Anti-Ageing Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Anti-Ageing Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Anti-Ageing Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Anti-Ageing Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Ageing Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anti-Ageing Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Anti-Ageing Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Anti-Ageing Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Anti-Ageing Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Anti-Ageing Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Anti-Ageing Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Anti-Ageing Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Anti-Ageing Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Anti-Ageing Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Anti-Ageing Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Anti-Ageing Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Anti-Ageing Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Anti-Ageing Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Anti-Ageing Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Anti-Ageing Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Anti-Ageing Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Anti-Ageing Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Anti-Ageing Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Anti-Ageing Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Anti-Ageing Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Anti-Ageing Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Anti-Ageing Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Anti-Ageing Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Anti-Ageing Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Anti-Ageing Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Anti-Ageing Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Anti-Ageing Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Anti-Ageing Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Anti-Ageing Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Anti-Ageing Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Anti-Ageing Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Anti-Ageing Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Anti-Ageing Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Anti-Ageing Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Anti-Ageing Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Anti-Ageing Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Anti-Ageing Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Anti-Ageing Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Anti-Ageing Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Anti-Ageing Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Anti-Ageing Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Anti-Ageing Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Anti-Ageing Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Anti-Ageing Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Anti-Ageing Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Anti-Ageing Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Anti-Ageing Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Anti-Ageing Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Anti-Ageing Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Anti-Ageing Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Anti-Ageing Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Anti-Ageing Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Anti-Ageing Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Anti-Ageing Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. Nu Skin Company Information
 Table 71. Nu Skin Description and Business Overview
 Table 72. Nu Skin Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Nu Skin Anti-Ageing Drugs Product
 Table 74. Nu Skin Recent Developments/Updates
 Table 75. BIOTIME Company Information
 Table 76. BIOTIME Description and Business Overview
 Table 77. BIOTIME Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. BIOTIME Anti-Ageing Drugs Product
 Table 79. BIOTIME Recent Developments/Updates
 Table 80. Elysium Health Company Information
 Table 81. Elysium Health Description and Business Overview
 Table 82. Elysium Health Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Elysium Health Anti-Ageing Drugs Product
 Table 84. Elysium Health Recent Developments/Updates
 Table 85. La Roche-Posay Company Information
 Table 86. La Roche-Posay Description and Business Overview
 Table 87. La Roche-Posay Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. La Roche-Posay Anti-Ageing Drugs Product
 Table 89. La Roche-Posay Recent Developments/Updates
 Table 90. DermaFix Company Information
 Table 91. DermaFix Description and Business Overview
 Table 92. DermaFix Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. DermaFix Anti-Ageing Drugs Product
 Table 94. DermaFix Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Anti-Ageing Drugs Distributors List
 Table 98. Anti-Ageing Drugs Customers List
 Table 99. Anti-Ageing Drugs Market Trends
 Table 100. Anti-Ageing Drugs Market Drivers
 Table 101. Anti-Ageing Drugs Market Challenges
 Table 102. Anti-Ageing Drugs Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anti-Ageing Drugs
 Figure 2. Global Anti-Ageing Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anti-Ageing Drugs Market Share by Type: 2024 & 2031
 Figure 4. Hormonal Therapy Product Picture
 Figure 5. Antioxidants Product Picture
 Figure 6. Enzymes Product Picture
 Figure 7. Stem Cells Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Anti-Ageing Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Anti-Ageing Drugs Market Share by Application: 2024 & 2031
 Figure 11. Skin
 Figure 12. Hair
 Figure 13. Others
 Figure 14. Global Anti-Ageing Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Anti-Ageing Drugs Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Anti-Ageing Drugs Sales (2020-2031) & (K Units)
 Figure 17. Global Anti-Ageing Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 18. Anti-Ageing Drugs Report Years Considered
 Figure 19. Anti-Ageing Drugs Sales Share by Manufacturers in 2024
 Figure 20. Global Anti-Ageing Drugs Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Anti-Ageing Drugs Players: Market Share by Revenue in Anti-Ageing Drugs in 2024
 Figure 22. Anti-Ageing Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Anti-Ageing Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Anti-Ageing Drugs Sales Market Share by Country (2020-2031)
 Figure 25. North America Anti-Ageing Drugs Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Anti-Ageing Drugs Sales Market Share by Country (2020-2031)
 Figure 29. Europe Anti-Ageing Drugs Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Anti-Ageing Drugs Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Anti-Ageing Drugs Revenue Market Share by Region (2020-2031)
 Figure 37. China Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Anti-Ageing Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Anti-Ageing Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Anti-Ageing Drugs Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Anti-Ageing Drugs Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Anti-Ageing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Anti-Ageing Drugs by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Anti-Ageing Drugs by Type (2020-2031)
 Figure 59. Global Anti-Ageing Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Anti-Ageing Drugs by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Anti-Ageing Drugs by Application (2020-2031)
 Figure 62. Global Anti-Ageing Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 63. Anti-Ageing Drugs Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Anti aging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Aging Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Grade Anti Aging Drugs Market Research Report 2024
Global Anti Senescence Therapy Market Insights Forecast to 2030
Global Skin Anti Aging Product Market Research Report 2025
Anti Ageing Ingredient Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Aging Agent Market Research Report 2024
Global Anti Ageing Active Ingredients Market Insights Forecast to 2030
Global Anti aging Devices Market Insights Forecast to 2030
Global Anti aging and Longevity Drugs Market Research Report 2024
Global Anti Aging Cream Market Insights Forecast to 2030
Global Anti aging Services Market Insights Forecast to 2030
Global Anti Aging Products and Therapies Market Insights Forecast to 2030
Global Anti Aging Hair Products Market Insights Forecast to 2030
Global Longevity and Anti senescence Therapy Market Insights Forecast to 2030
Global Anti Aging and Regenerative Product Market Research Report 2024
Anti aging Products and Healthy Drinks Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Aging Therapies Market Research Report 2024
Global Anti aging Beauty Products Market Research Report 2024
Global Anti aging Cosmetics Products Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions